1990
DOI: 10.1097/00003072-199002000-00001
|View full text |Cite
|
Sign up to set email alerts
|

Tc-99m White Cell Scintigraphy in Suspected Acute Infection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

1993
1993
2017
2017

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 14 publications
(6 citation statements)
references
References 0 publications
0
6
0
Order By: Relevance
“…Hence, by mapping the location of Sn within neutrophils we can infer the location of Tc, that is, with XFM we can use Sn as a "tracer" for the location of Tc. In the clinical setting TcSn colloid has consistently proven efficacious in detecting focal infection [4][5][6][7][8]. Some studies have reported pessimistically on TcSn colloid leukocyte labelling efficiency [9]; however, such studies may not use the standard labelling method.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Hence, by mapping the location of Sn within neutrophils we can infer the location of Tc, that is, with XFM we can use Sn as a "tracer" for the location of Tc. In the clinical setting TcSn colloid has consistently proven efficacious in detecting focal infection [4][5][6][7][8]. Some studies have reported pessimistically on TcSn colloid leukocyte labelling efficiency [9]; however, such studies may not use the standard labelling method.…”
Section: Discussionmentioning
confidence: 99%
“…TcSn colloid (LLK Radpharm Australia) is a commercially available radiopharmaceutical used to label phagocytic leukocytes to image sites of infection [4][5][6][7][8]. When fresh colloid is examined immediately after manufacture it is found to consist of clumps of particles measuring on the order of several micrometers [9,10].…”
Section: Introductionmentioning
confidence: 99%
“…Tc-labled stannous colloids ( 99m Tc-SnC) is a radiolabeling technique to label neutrophils and monocytes for imaging of inflammation and spatial localization of infection for gram-positive as well as gram-negative bacteria [21][22][23][24][25][26].…”
Section: M Tc-stannous Colloid 99mmentioning
confidence: 99%
“…Although 99m TcSnC is not approved for human use in the United States, 10 it is approved in Australia for investigation of inflammatory disorders in people 11–17 . The main advantage of 99m TcSnC over other in vitro labeling radiopharmaceuticals is its ability to radiolabel leukocytes in whole blood, thereby obviating the need for separation of leukocytes.…”
Section: Introductionmentioning
confidence: 99%
“…The main advantage of 99m TcSnC over other in vitro labeling radiopharmaceuticals is its ability to radiolabel leukocytes in whole blood, thereby obviating the need for separation of leukocytes. This ensures that the labeling procedure is simple, fast, and safe 11–17 . 99m TcSnC is also less expensive than other radiopharmaceuticals.…”
Section: Introductionmentioning
confidence: 99%